Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Digest Yemen.
Press releases published on October 2, 2025
Poppulo Menjadi Syarikat Komunikasi Pekerja dan Papan Tanda Digital Pertama yang Meraih Pensijilan ISO Penanda Aras bagi AI Bertanggungjawab
DENVER dan CORK, Ireland, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Poppulo, peneraju global dalam komunikasi pekerja dan papan tanda digital, hari ini mengumumkan bahawa mereka telah mencapai penanda aras baharu bagi AI bertanggungjawab, iaitu pensijilan ISO …
Poppulo É a Primeira Empresa de Comunicações e Sinalização Digital de Funcionários a Obter a Certificação ISO de Referência Como IA Responsável
DENVER e CORK, Irlanda, Oct. 02, 2025 (GLOBE NEWSWIRE) -- A Poppulo, líder global em comunicações de funcionários e sinalização digital, anunciou hoje que alcançou a nova referência como IA responsável, a certificação ISO 42001. Ela é a única empresa da …
Datavault AI Converts $13.3 Million in Convertible Debt, Strengthens Balance Sheet
BEAVERTON, Ore., Oct. 02, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (Nasdaq: DVLT), a pioneer in AI-driven data monetization, today announced the full conversion of certain long term notes with an aggregate original face value of $13.3 million …
AiSprouts Launches Founder Bootcamp Program to Support the Next Wave of Capital-Efficient Artificial Intelligence Startups
San Francisco, CA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- AiSprouts VC (https://www.aisprouts.com/), a boutique Silicon Valley venture capital firm specializing in breakthrough AI startups advancing human potential, today announced the expansion of its …
SmartDeFi™ Announces GENIUS Act-Compatible Token Launching Options
Dubai, UAE, Oct. 02, 2025 (GLOBE NEWSWIRE) -- SmartDeFi™, the twice-audited next-generation token launchpad, today announced support for project creators to pair their tokens at launch with stablecoins designed to meet GENIUS Act standards, such as $USDC, …
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Mevolaxy Introduces New mevjrv12 Algorithm, Offering users Record Profits
Los Angeles, CA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Mevolaxy team continues to develop its own technology and introduce innovations into the mechanics of its MEV bot network. They recently unveiled a new algorithm called mevjrv12. Its key feature is a …
Matrack Takes Home Two Awards at 2025 NATDA Trailer Show Innovation Showcase
SAN RAMON, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Matrack Inc., a leading provider of Al-based GPS fleet management solutions, announced today that it has won two prestigious awards at the 2025 NATDA Trailer Show Innovation Showcase held at the Music …
Folks Achieves Prestigious Ranking in Canada's Top Growing Companies 2025
Quebec City, QC, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Folks, a leading Canadian HR software solution provider, has been ranked #109 out of 400 companies in the prestigious Canada's Top Growing Companies 2025 list by the Globe and Mail. This recognition …
Cardiff Oncology to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will …
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
Rumble and Perplexity Enter into a Strategic Partnership
Collaboration to drive improved video discovery on Rumble by leveraging Perplexity AI tools Rumble will introduce a new bundled subscription offer combining Perplexity Pro with Rumble Premium Partnership includes an advertising commitment from Perplexity …
Dyne Therapeutics Appoints Brian Posner to its Board of Directors
WALTHAM, Mass., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the appointment …
Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option
Offering was led by B Group Capital and Columbia Threadneedle Investments with significant participation from Adage Capital Partners LP, ADAR1 Capital Management, Boxer Capital Management, Coastlands Capital, Deep Track Capital, Janus Henderson Investors, …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …